Freestone Capital Holdings LLC grew its stake in MetLife, Inc. (NYSE:MET) by 3.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,746 shares of the financial services provider’s stock after acquiring an additional 678 shares during the period. Freestone Capital Holdings LLC’s holdings in MetLife were worth $1,250,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of MET. First Personal Financial Services grew its stake in MetLife by 11.5% in the 1st quarter. First Personal Financial Services now owns 2,588 shares of the financial services provider’s stock worth $137,000 after acquiring an additional 266 shares in the last quarter. Westside Investment Management Inc. grew its stake in MetLife by 583.8% in the 1st quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock worth $140,000 after acquiring an additional 2,300 shares in the last quarter. Parallel Advisors LLC grew its stake in MetLife by 50.7% in the 1st quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock worth $143,000 after acquiring an additional 924 shares in the last quarter. CI Investments Inc. bought a new position in MetLife in the 1st quarter worth about $158,000. Finally, First Mercantile Trust Co. grew its stake in MetLife by 3.4% in the 2nd quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock worth $161,000 after acquiring an additional 97 shares in the last quarter. Institutional investors and hedge funds own 74.14% of the company’s stock.

TRADEMARK VIOLATION WARNING: “MetLife, Inc. (MET) Shares Bought by Freestone Capital Holdings LLC” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/09/21/metlife-inc-met-shares-bought-by-freestone-capital-holdings-llc.html.

MetLife, Inc. (NYSE MET) opened at 50.13 on Thursday. MetLife, Inc. has a 12-month low of $38.17 and a 12-month high of $51.77. The firm has a 50 day moving average of $47.80 and a 200-day moving average of $47.30. The stock has a market cap of $53.28 billion, a PE ratio of 589.76 and a beta of 1.44.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business had revenue of $17.39 billion during the quarter, compared to analysts’ expectations of $17.11 billion. During the same quarter in the prior year, the business posted $0.83 EPS. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, analysts expect that MetLife, Inc. will post $4.77 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 13th. Stockholders of record on Monday, August 7th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 3.19%. The ex-dividend date was Thursday, August 3rd. MetLife’s payout ratio is 1,777.98%.

MET has been the topic of a number of research analyst reports. ValuEngine upgraded shares of MetLife from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Citigroup Inc. set a $51.00 target price on shares of MetLife and gave the stock a “sell” rating in a research note on Friday, July 7th. BidaskClub upgraded shares of MetLife from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 10th. UBS AG restated a “neutral” rating and issued a $49.00 target price (down from $57.00) on shares of MetLife in a research note on Friday, September 1st. Finally, J P Morgan Chase & Co initiated coverage on shares of MetLife in a research note on Monday, July 24th. They issued a “hold” rating and a $78.00 target price on the stock. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $57.95.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.